期刊文献+

人乳头瘤病毒(6/11,16/18)核酸实时荧光PCR检测室内质控品研制及应用 被引量:2

Human Papillomavirus (6/11,16/18) Nucleic Acid Fluorescence in Real-time PCR Detection of Indoor Control Materials Research and Application
下载PDF
导出
摘要 目的研制HPV(6/11),(16/18)型核酸质控品应用于实时荧光PCR检测分析的室内质量控制。方法采用HPV(6/11)型和HPV(16/18)型荧光定量PCR诊断试剂盒,对患者的分泌物进行FQ-PCR检测。提取双阳性分泌物,经适当灭活后,将HPV(6/11),(16/18)型核酸模式的阳性混合标本经过回收、防腐、调剂及分装等流程,制成中、高值各3个批次的质控品,完成校准和比对试验。分别进行不少于6个月的室内质控检测,观察其稳定性,确定其靶值。计算5,CV,绘制质控图。结果各批次质控品前6个月的HPV(6/11),(i6/18)型核酸质控品相对稳定(P〈0.05)。质控物高低值的变异范围分别为1.99%和2.61%(CV〈5%),批问差CV〈10%,稳定性好。结论HPV型模式的阳性混合标本制备定量检测的HPV(6/11),(16/18)型核酸质控品的稳定性好,可用于HPV(6/11),(16/18)型核酸荧光定量的PCR诊断的室内质量控制,测定结果能反应标本的真实性,有一定的临床实用价值。 Objective To develop of HPV (6/11), (16/18) nucleic acid control materials used in real-time fluorescence PCR assay analysis of internal quality control. Methods With of HPV (6/11) type and HPV (16/18) fluorescence quantitative PCR diagnostic kit,detected the secretions of patients with FQ-PCR. Extraction of double-positive secretions inactivated, ac- cording to HPV (6/11), (16/18)-type nucleic acid positive mixed mode specimens, after recovery, corrosion,dispensing and repackaging process, made of high values of three batches of quality control materials and completed the calibration and com- parisontest. Then made not less than eight months of internal quality control inspection,observation of its stability,and de- termined its target value,calculation,s, CV, drawing quality control chart. Results Each batch quality control materials of the first six months of HPV (6/11), (16/18) nucleic acid control materials was relatively stable ( P〈 0.05), the range of variation of quality control high and low values were 1.99% ,2.61% (CV(5G) and between-run CV〈10%. Conclusion Positive mixed sample preparation for quantitative detection of HPV type model of HPV (6/11), (16/18) nucleic acid con- trol materials had stability and it can be used for HPV (6/11), (16/18) nucleic acid fluorescence quantitative PCR diagnostic internal quality control, determination of the results reflect the authenticity of the specimens, the clinical value.
作者 裴兵
机构地区 泗洪县人民医院
出处 《现代检验医学杂志》 CAS 2012年第5期154-157,共4页 Journal of Modern Laboratory Medicine
关键词 实时荧光定量PCR 质控品 人乳头状瘤(HPV) Keywords : real-time PCR control materials human papillomavirus ( H PV)
  • 相关文献

参考文献10

  • 1Cacciola I, Spatari G, Pollicino T, et al. Virological profiles in hepatitis B virus inactive carriers:monthly evaluation in 1-year follow-up study[J]. Liver Int, 2005,25 (3): 555-563.
  • 2杨玲,皇甫小梅,张思维,鲁凤珠,孙秀娣,孙杰,牧人,李连弟,乔友林.中国20世纪70年代与90年代子宫颈癌死亡率及其变化趋势[J].中国医学科学院学报,2003,25(4):386-390. 被引量:84
  • 3尹文友,曾红霞.临床检验标本的质量控制与管理对策[J].检验医学与临床,2007,4(1):61-62. 被引量:10
  • 4张势华,林世平,张智勇.医院检验科IS()15189规范管理制度范本[M].北京:中国计量出版社,2009.
  • 5Nagao S, Yoshinouchi M, Miyagi Y, et al. Rapid and sensitive detection of physical status of human papib lomavirus type 16 DNA by quantitative real-time PCR[J]. J Clin Microbiol, 2002,40 (3) : 863-867.
  • 6Peitsaro P,Johansson B, Syrjanen S. Integrated hu- man papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique[J]. J Clin Microbiol, 2002,40 (3) :886-891.
  • 7El-Mofty SK, Patil S. Human papillomavirus(HPV)- related orophyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006,101 (3) : 339-345.
  • 8Ji SL, Ding YD,Tzang CH,et al. Prevalence and gen- otype evaluation of cervical human papillomavirus (HPV)in Southern China by genotyping DNA array [S]. China : Beijing, Oral Presentation 14 : 00 - 15 :40 section 2:HPV epidemiology I,the 24th International Papilloma-virus Conference&Clinical Workshop Pro-gram Book 2B-03 : 2007.
  • 9Wright TC, Denny L, Kuhn L,et al. HPV DNA tes- ting of self-collected vaginal samples compared with cytologic screening to detect cervical cancer[J]. JA- MA. 2000,283(1):81-86.
  • 10Einstein MH,Studentsov YY, Ho GY,et al. Combi- ned human papillomavirus DNA and human papillo- mavirus-like particle serologic assay to identify women at risk for fish-grade cervical intraepithelial neoplasia[J]. Int J Cancer,2007,120(1) :55-59.

二级参考文献20

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979,1..
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4蒋秉坤.临床生物化学及生物化学检验.北京:人民卫生出版社,1996,5.
  • 5Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin, 1999, 49(1):33-64.
  • 6Franeo EL, Duarte-Franco E, Ferenezy A. Cervical cancer:epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 2001, 164(7):1017-1025.
  • 7Zlaang ZF, Parkin DM, Yu SZ, et al. Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer, 1989, 43:762-767.
  • 8International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risks to humans,human papillomaviruses. Vol 64. Lyon: IARC Press, 1995.
  • 9Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papiUomavims in cervical cancer, the IARC multicentric case-control study. Lancet, 2002, 359:1093-1101.
  • 10Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer, 1995, 76(10 Suppl):1888-1901.

共引文献92

同被引文献20

  • 1谢珊,李金明.人乳头瘤病毒16,18型核酸检测质控物的研制及应用[J].中华医学杂志,2007,87(26):1862-1866. 被引量:3
  • 2中国合格评定国家认可委员会.CNAS-GL03《能力验证样品均匀性和稳定性评价指南》[S].中国合格评定国家认可委员会,2006.
  • 3Chen W, Zhang X, Molijn A, et al. Human papillomavirus type-dis- tribution in cervical cancer in China: the importance of HPV 16 and 18 [J]. Cancer Causes Control, 2009, 20 (9) : 1705-1713.
  • 4Nancler P, Ryd W, Tomberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer[J]. N Engl J Med, 2007, 357 (16) : 1589-1597.
  • 5Eklund C, Forslund O, Wallin KL, et al. The 2010 global proficien- cy study of human papillomavirus genotyping in vaccinology [J]. J Clin Microbiol, 2012, 50(7) :2289-2298.
  • 6Zhang R, Huang J, Wang P, et al. Proficiency test for human papillo- mavirus geuotyping in china[J]. Intervirology, 2013, 56(5):295-301.
  • 7Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines [J]. J Gen Virol, 1999, 80 ( Pt 7 ) : 1725-1733.
  • 8郭艳利,耿力,游珂,乔杰.高危型人乳头瘤病毒检测对宫颈病变的临床价值[J].临床检验杂志,2008,26(6):453-454. 被引量:6
  • 9黄杰,曲守方,徐任,高尚先.人乳头瘤病毒基因分型质控品的建立[J].中华检验医学杂志,2010,33(6):559-562. 被引量:9
  • 10周莹,许冰莹.二代测序技术在临床医学上的相关应用[J].昆明医科大学学报,2016,37(3):137-139. 被引量:8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部